Latest News & Features
Biotechnology
Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer. 9 June 2014
Big Pharma
Pharmaceutical professionals should have a “wide-ranging” debate on how IP can be tailored in the face of “major changes” to the industry, including the possibility of “prolonged exclusivity” for certain medicines, according to a report. 6 June 2014
Americas
Pfizer and Mylan have agreed to settle litigation related to arthritis treatment Celebrex (celecoxib), Mylan announced today, June 2. 2 June 2014
Big Pharma
A pharmaceutical company in Turkey has run into trouble after attempting to register the Turkish word for ‘pharmacist’ as a trademark. 29 May 2014
Big Pharma
Teva has successfully defended a patent for its multiple sclerosis drug Copaxone (glatiramer acetate) in Europe. 28 May 2014
Biotechnology
Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked. 27 May 2014
Americas
US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone). 23 May 2014
Europe
Generics (UK) Limited, the UK arm of Mylan, has succeeded in invalidating a patent held by Hungarian pharmaceutical company Richter Gedeon at the English High Court. 22 May 2014
Americas
Medical device rivals Medtronic and Edwards Lifesciences have agreed to settle all patent litigation, including cases related to transcatheter heart valves. 21 May 2014
Generics
The United Nations Development Programme has released a guidebook for low- to middle- income countries on how to increase access to essential health technologies and HIV treatments by using competition law and policy. 20 May 2014